"Will I actually get approved?" It's the first question most people ask before they start an eligibility quiz — and it's a fair one. Nobody wants to fill in a form, get their hopes up, and hit a wall. So here is the honest answer, straight from the prescription rules: weight-loss injections in Ireland are licensed for adults with a BMI of 30 or above, or a BMI of 27–30 alongside at least one weight-related health condition — and a prescription only ever follows a doctor's review of your full medical history.
Quick answer (checked 22 September 2026): if your BMI is 30+, or between 27 and 30 with a condition like high blood pressure, high cholesterol, sleep apnoea, prediabetes, type 2 diabetes or cardiovascular disease, you meet the medical criteria the licence sets out — and the final decision sits with a prescribing doctor who reviews your history. You can check where you stand in about two minutes.
Try the Slimbr weight loss plan
First month service fee just €49. If the doctor decides it's not suitable for you, your doctor consultation is free.
The two routes to eligibility
Every weight-loss injection available in Ireland — Wegovy, Mounjaro and Saxenda — is a prescription-only medicine, and the European licence sets out two routes to qualifying. They're almost identical across the injections, which keeps things simple:
- Route 1 — BMI of 30 or above. This is the obesity range. No other condition is needed; the BMI threshold alone satisfies the licence.
- Route 2 — BMI of 27 to under 30, plus at least one weight-related health condition. This is the "overweight with a comorbidity" route. You need both parts: the BMI band and a qualifying condition from the licence's list.
In the licence wording, both routes are "as an adjunct to a reduced-calorie diet and increased physical activity" — these medicines are prescribed alongside lifestyle change, not instead of it. That framing matters, and it's how any legitimate Irish clinic will treat them. Our complete Mounjaro Ireland guide covers what the treatment itself involves.
| Medicine | BMI 30+ | BMI 27–30 + weight-related condition |
|---|---|---|
| Mounjaro (tirzepatide) | Eligible | Eligible |
| Wegovy (semaglutide) | Eligible | Eligible |
| Saxenda (liraglutide) | Eligible | Eligible (subset of conditions) |
One note on Saxenda: it's licensed in Ireland and — uniquely among the three — HSE-reimbursed under a strict protocol, but Slimbr doesn't supply it; the treatments prescribed through our service are Mounjaro and Wegovy.
The weight-related conditions that count
If your BMI sits between 27 and 30, the licence needs at least one weight-related comorbidity. The lists in the European product information for Mounjaro and Wegovy cover the same ground:
- High blood pressure (hypertension)
- High cholesterol or triglycerides (dyslipidaemia)
- Obstructive sleep apnoea
- Cardiovascular disease
- Prediabetes
- Type 2 diabetes
You only need one of these — not the full set. And you don't need to self-diagnose: the medical questionnaire asks about diagnosed conditions and current medicines, and the doctor's review is where it gets confirmed. If you're not sure whether something you live with counts, put it in the form and let the clinician judge it; under-declaring is the only way to get a wrong answer.
"But I asked about Ozempic"
Plenty of people arrive at this question having only ever heard the word "Ozempic" — it became shorthand for weight-loss injections everywhere from newspapers to group chats. In Ireland, though, Ozempic is licensed for type 2 diabetes, not for weight loss. The semaglutide injection licensed for weight management is Wegovy: same active ingredient, different product, different licence.
So if your real question is "will I be approved for the weight-loss injection everyone's talking about?", the criteria in this article are the ones that apply. And if you've been offered "Ozempic for weight loss" outside a prescription process, that's worth pausing on — Ireland's regulator has warned about unregulated sales of weight-loss injections, and any legitimate route runs through a doctor's review first.
What the doctor checks besides your BMI
Meeting the BMI criteria gets you to the review — it doesn't end there. A BMI threshold is where the conversation starts, not where it ends. Before prescribing, a doctor working within the licence will look at:
- Your full medical history — diagnosed conditions, past and present
- Current medicines, because interactions matter for any prescription
- Previous reactions to similar medicines, and any allergies (the product information lists hypersensitivity to the active substance as a contraindication)
- Pregnancy, breastfeeding or plans to conceive — these medicines are not recommended during pregnancy, and contraception is advised for women of childbearing potential while using them
- Conditions that call for caution — the product information carries a special-warnings section (for example, a history of pancreatitis or gallbladder problems); the prescriber weighs these against the potential benefits for your situation
This review isn't a box-tick. It's the part of the process that makes a private prescription legitimate — and it's why "do I qualify?" is genuinely a two-part answer: the licence criteria get you in the door, and the doctor's judgement decides what's medically appropriate for you specifically.
Try the Slimbr weight loss plan: first month service fee just €49 →
When the answer is no
For honesty's sake, here's the other side. You won't be prescribed a weight-loss injection if:
- Your BMI is under 27 and you have no qualifying weight-related condition — the licence simply doesn't cover it, and no legitimate clinic will prescribe outside it
- You're pregnant or breastfeeding — not recommended, full stop
- You've had a hypersensitivity reaction to the active substance before
- The doctor judges the risks outweigh the benefits in your specific case, on the basis of your history or current medicines
A "no" today is rarely a "never" — weight, blood pressure and prediabetes all move, and a doctor can tell you what would need to change. It's also worth saying plainly: a prescription is not a reward or a judgement. It's a medical decision with published criteria, and you're entitled to a clear reason for whatever the answer is.
Did you know you can claim up to 75% back on your health insurance?
See how the claim works →What it costs once you're eligible
Eligibility and affordability are different questions, so here's the short version of the money side. With an online doctor service like Slimbr, you pay two parties:
- A monthly service fee to Slimbr — €49 — which covers the doctor review, your treatment plan and clinical support
- The medication, paid to the independent partner pharmacy — from about €180 a month for the starting dose of Mounjaro at current prices, with Wegovy's lower doses priced below that. The pharmacy also charges delivery separately.
So a typical first month starts from around €229 in total, monthly plans after that start at €279 in total depending on dose, and the 6-month plan works out at about €253 per month. Doses are reviewed as treatment progresses, and the dose affects the pharmacy price — our full Ireland price comparison breaks down every dose and provider.
Medical card and the Drugs Payment Scheme
The HSE's schemes generally don't cover weight-loss injections: Mounjaro and Wegovy for weight management aren't on the reimbursement list, so the prescription is private regardless of whether you hold a medical card or DPS card. The one exception is Saxenda — it is reimbursed under a strict Managed Access Protocol (broadly a BMI of 35 or higher plus prediabetes and high cardiovascular risk, with continued funding conditional on results). We cover the detail, including what the DPS does and doesn't cap, in will Mounjaro ever be free on the HSE?
If you are considering treatment, the starting point is the same as it always was: a proper medical assessment, a clinician who can say no, and a plan built around your health.
Frequently asked questions
What BMI do you need for Mounjaro in Ireland?
A BMI of 30 or above, or a BMI of 27–30 with at least one weight-related condition such as high blood pressure, sleep apnoea or prediabetes. That's the licence criteria; a doctor then reviews your full history before prescribing.
Do I need a BMI over 30 for Wegovy?
No — Wegovy uses the same two routes as Mounjaro: BMI 30+, or BMI 27–30 with a weight-related comorbidity. The comorbidity lists for the two medicines cover the same conditions.
Can I get Ozempic for weight loss in Ireland?
Ozempic is licensed in Ireland for type 2 diabetes, not weight management. The semaglutide injection licensed for weight loss is Wegovy. Any offer of "Ozempic for weight loss" outside a prescription process is not a legitimate route.
Does a medical card or DPS card cover weight-loss injections?
Generally no — Mounjaro and Wegovy for weight management aren't on the HSE reimbursement list. Saxenda is the one exception, reimbursed under a strict Managed Access Protocol (broadly BMI 35+ plus prediabetes and high cardiovascular risk).
Can my own GP prescribe Mounjaro or Wegovy?
These are prescription-only medicines, so any prescribing doctor working within the licence can prescribe them. In practice, many people use an online doctor service because the review, the prescription and the pharmacy hand-off are handled in one place — but the medical criteria are the same either way.
Further reading
- Mounjaro in Ireland: the complete guide — how the treatment works, the dose ladder and follow-up
- Every weight-loss medication licensed in Ireland — injections, tablets and pharmacy options compared
- Mounjaro prices in Ireland compared — every dose, every provider
- Will Mounjaro be free on the HSE? — medical card, DPS and the Saxenda exception
Sources: European Medicines Agency product information for Mounjaro and Wegovy (sections 4.1, 4.3, 4.6), checked 22 September 2026. This article explains prescription criteria; it is not medical advice, and eligibility for any prescription is decided by a doctor.
